L. Paolozzi

发表

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate‐to‐severe plaque psoriasis: a randomized controlled trial with open‐label extension

T. Luger, S. Segaert, M. Lahfa, 2008, The British journal of dermatology.

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis

S. van der Linden, B. Dijkmans, D. M. van der Heijde, 2009, The Journal of Rheumatology.

Knee joint space width measurement: an experimental study of the influence of radiographic procedure and joint positioning.

M. Dougados, P. Ravaud, C. Chastang, 1996, British journal of rheumatology.

Efficacy of epidural steroids in low back pain and sciatica. A critical appraisal by a French Task Force of randomized trials. Critical Analysis Group of the French Society for Rheumatology.

P. Ravaud, L. Paolozzi, S. Rozenberg, 1999, Revue du rhumatisme.

Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section.

T. Spector, C. Cooper, M. Dougados, 1996, Annals of the rheumatic diseases.

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ETANERCEPT 25 TWICE WEEKLY IN PATIENTS WITH SEVERE PERSISTENT ASTHMA

I. Pavord, W. Busse, S. Holgate, 2007 .

Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis

M. Dougados, P. Ravaud, P. Dieppe, 2004, Annals of the rheumatic diseases.

Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial

I. Pavord, W. Busse, S. Holgate, 2010, European Respiratory Journal.

Tiopronine-induced reduction of rheumatoid factor functional affinity and asialylated IgG in patients with rheumatoid arthritis.

P. Youinou, L. Paolozzi, B. Bendaoud, 1992, Clinical and Experimental Rheumatology.

Clinical profile, contemporary management and one‐year mortality in patients with severe acute heart failure syndromes: The EFICA study ☆

A. Cohen-Solal, A. Mebazaa, F. Alla, 2006, European journal of heart failure.

Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

P. V. D. van de Kerkhof, S. Segaert, K. Reich, 2009, Dermatology.

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA

N. Goel, J. Reginster, A. Laslop, 2011, Current medical research and opinion.

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis

M. Dougados, I. Olivieri, D. M. van der Heijde, 2006, Annals of the rheumatic diseases.

Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis

M. Dougados, B. Giraudeau, C. Chastang, 1998, Annals of the rheumatic diseases.

Evaluation of symptomatic and structural efficacy of a new hyaluronic acid (HA) compound, (NRD101), when compared to diacerein and placebo in a one-year randomized controlled study in symptomatic knee

P. Ravaud, P. Dieppe, L. Paolozzi, 2004 .

Etanercept 50 mg once weekly improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis (Abstract)

S. Segaert, M. Boussuge, L. Paolozzi, 2008 .

Interleukin-1 and naproxen down-regulate the expression of IL-1 receptors in cultured human rheumatoid synovial cells (HRSC).

D. Vivien, L. Paolozzi, P. Galéra, 1993, Agents and actions. Supplements.